Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor
Bone metastasis is the lethal end‐stage of prostate cancer (PC), but the biology of bone metastases is poorly understood. The overall aim of this study was therefore to explore molecular variability in PC bone metastases of potential importance for therapy. Specifically, genome‐wide expression profi...
Main Authors: | Elin Thysell, Linda Vidman, Erik Bovinder Ylitalo, Emma Jernberg, Sead Crnalic, Diego Iglesias‐Gato, Amilcar Flores‐Morales, Pär Stattin, Lars Egevad, Anders Widmark, Patrik Rydén, Anders Bergh, Pernilla Wikström |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-08-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.12526 |
Similar Items
-
Characterization of prostate cancer bone metastases according to expression levels of steroidogenic enzymes and androgen receptor splice variants.
by: Emma Jernberg, et al.
Published: (2013-01-01) -
Expression of androgen receptor splice variants in prostate cancer bone metastases is associated with castration-resistance and short survival.
by: Emma Hörnberg, et al.
Published: (2011-04-01) -
A Novel Radiographic Pattern Related to Poor Prognosis in Patients with Prostate Cancer with Metastatic Spinal Cord Compression
by: Johan Wänman, et al.
Published: (2023-02-01) -
High Lysyl Oxidase (LOX) in the Non-Malignant Prostate Epithelium Predicts a Poor Outcome in Prostate Cancer Patient Managed by Watchful Waiting.
by: Maria Nilsson, et al.
Published: (2015-01-01) -
Metastatic spinal cord compression as the first sign of malignancy: Outcome after surgery in 69 patients
by: Johan Wänman, et al.
Published: (2017-07-01)